Reference for Chapter 44: Urticarial Vasculitis - Rooks Textbook of Dermatology

1 McDuffie FC, Sams WM Jr, Maldonado JE, Andreini PH, Conn DL, Samayoa EA. Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome. Mayo Clin Proc 1973 May;48(5):340–8. Pubmed link
2 Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol 2000;12:24–31. Cross Ref link Pubmed link
3 Mehregan DR, Gibson LE. Pathophysiology of urticarial vasculitis. Arch Dermatol 1998 Jan;134:88–9. Cross Ref link Pubmed link
4 O'Donnell B, Black AK. Urticarial vasculitis. Int Angiol 1995;14(2):166–74. Pubmed link
5 Black AK. Urticarial vasculitis. Clin Dermatol 1999;17:565–9. Cross Ref link Pubmed link
6 Soter NA. Urticarial venulitis. Derm Ther 2000;13:400–8. Cross Ref link
7 Krause K, Mahamed A, Weller K, Metz M, Zuberbier T, Maurer M. Efficacy and safety of canakinumab in urticarial vasculitis: an open‐label study. J Allergy Clin Immunol 2013;132:751–4. Cross Ref link Pubmed link
8 Tosoni C, Lodi‐Rizzini F, Cinquini M, et al. A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients. Clin Exp Dermatol 2009;34(2):166–70. Cross Ref link Pubmed link
9 Aboobaker J, Greaves MW. Urticarial vasculitis. Clin Exp Dermatol 1986;11(5):436–44. Cross Ref link Pubmed link
10 Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992;26(3 Pt 2):441–8. Cross Ref link Pubmed link
11 Schwartz HR, McDuffie FC, Black LF, Schroeter AL, Conn DL. Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. Mayo Clin Proc 1982;57(4):231–8. Pubmed link
12 Buck A, Christensen J, McCarty M. Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review. J Clin Aesthet Dermatol 2012;5(1):36–46. Pubmed link
13 Martini A, Ravelli A, Albani S, De Benedetti F, Massa M, Wisnieski JJ. Hypocomplementemic urticarial vasculitis syndrome with severe systemic manifestations. J Pediatr 1994;124(5 Pt 1):742–4. Cross Ref link Pubmed link
14 Sanchez NP, Winkelmann RK, Schroeter AL, Dicken CH. The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases. J Am Acad Dermatol 1982;7(5):599–605. Cross Ref link Pubmed link
15 Lee JS, Loh TH, Seow SC, Tan SH. Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis. J Am Acad Dermatol 2007;56(6):994–1005. Cross Ref link Pubmed link
16 Venzor J, Lee WL, Huston DP. Urticarial vasculitis. Clin Rev Allergy Immunol 2002;23:201–16. Cross Ref link Pubmed link
17 Asherson RA, D'Cruz D, Stephens CJ, McKee PH, Hughes GR. Urticarial vasculitis in a connective tissue disease clinic: patterns, presentations and treatment. Semin Arthritis Rheum 1991;20(5):285–96. Cross Ref link Pubmed link
18 Alexander EL, Provost TT. Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti‐Ro(SSA) antibodies. J Invest Dermatol 1983;80(5):386–91. Cross Ref link Pubmed link
19 Kelkar PS, Butterfield JH, Kalaaji AN. Urticarial vasculitis with asymptomatic chronic hepatitis C infection: response to doxepin, interferon‐alfa and ribavirin. J Clin Gastroenterol 2002;35(3):281–2. Cross Ref link Pubmed link
20 Wands JR, Perrotto JL, Isselbacher KJ. Circulating immune complexes and complement sequence activation in infectious mononucleosis. Am J Med 1976;60:269–72. Cross Ref link Pubmed link
21 Olson JC, Esterly NB. Urticarial vasculitis and Lyme disease. J Am Acad Dermatol 1990;22:1114–16. Cross Ref link Pubmed link
22 Highet AS. Urticarial vasculitis and IgA myeloma. Br J Dermatol 1980;102(3):355–7. Cross Ref link Pubmed link
23 Lewis JE. Urticarial vasculitis occurring in association with visceral malignancy. Acta Derm Venereol 1990;70(4):345–7. Pubmed link
24 Grotz W, Baba HA, Becker JU, Baumgärtel MW. Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge. Dtsch Arztebl Int 2009;106:756–63. Pubmed link
25 Lipsker D. The Schnitzler syndrome. Orphanet J Rare Dis 2010;5:38. Cross Ref link Pubmed link
26 Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle–Wells syndrome and response to anakinra. Arthritis Rheum 2004;50(2):607–12. Cross Ref link Pubmed link
27 Van Doornum S, McColl G, Walter M, Jennens I, Bhathal P, Wicks IP. Prolonged prodrome, systemic vasculitis and deafness in Cogan's syndrome. Ann Rheum Dis 2001;60(1):69–71. Cross Ref link Pubmed link
28 Kano Y, Orihara M, Shiohara T. Cellular and molecular dynamics in exercise‐induced urticarial vasculitis lesions. Arch Dermatol 1998;134:62–7. Cross Ref link Pubmed link
29 Gammon WR. Urticarial vasculitis. Dermatol Clin 1985;3:97–105. Cross Ref link Pubmed link
30 D'Cruz DP, Wisnieski JJ, Asherson RA, Khamashta MA, Hughes GR. Autoantibodies in systemic lupus erythematosus and urticarial vasculitis. J Rheumatol 1995;22(9):1669–73. Pubmed link
31 Athanasiadis GI, Pfab F, Kollmar A, Ring J, Ollert M. Urticarial vasculitis with a positive autologous serum skin test: diagnosis and successful therapy. Allergy 2006;61(12):1484–5. Cross Ref link Pubmed link
32 Jones RR, Eady RA. Endothelial cell pathology as a marker for urticarial vasculitis: a light microscopic study. Br J Dermatol 1984;110(2):139–49. Cross Ref link Pubmed link
33 Hunt BJ, Jurd KM. The endothelium in health and disease. In: Hunt BJ, Poston L, Schachter M, Halliday A, eds. An Introduction to Vascular Biology: from basic science to clinical practice. Cambridge: Cambridge University Press, 2002:186–215. Cross Ref link
34 Zax RH, Hodge SJ, Callen JP. Cutaneous leukocytoclastic vasculitis. Serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. Arch Dermatol 1990;126(1):69–72. Cross Ref link Pubmed link
35 Guitart J. “Lymphocytic vasculitis” is not urticarial vasculitis. J Am Acad Dermatol 2008;59(2):353. Cross Ref link Pubmed link
36 Monroe EW. Urticarial vasculitis: an updated review. J Am Acad Dermatol 1981;5(1):88–95. Cross Ref link Pubmed link
37 Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology 2010;56:3–23. Cross Ref link Pubmed link
38 Jones RR, Bhogal B, Dash A, Schifferli J. Urticaria and vasculitis: a continuum of histological and immunopathological changes. Br J Dermatol 1983;108(6):695–703. Cross Ref link Pubmed link
39 Phanuphak P, Kohler PF, Stanford RE, Schocket AL, Carr RI, Claman HN. Vasculitis in chronic urticaria. J Allergy Clin Immunol 1980 Jun;65(6):436–44. Cross Ref link Pubmed link
40 Chen K‐R, Carlson J. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008;9(2):330–7.
41 Davis MD, Daoud MS, Kirby B, Gibson LE, Rogers RS 3rd. Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol 1998;38(6 Pt 1):899–905. Cross Ref link Pubmed link
42 Wisnieski JJ, Emancipator SN, Korman NJ, Lass JH, Zaim TM, McFadden ER. Hypocomplementemic urticarial vasculitis syndrome in identical twins. Arthritis Rheum 1994;37(7):1105–11. Cross Ref link Pubmed link
43 Ozçcakar ZB, Foster J 2nd, Diaz‐Horta O, et al. DNASE1L3 mutations in hypocomplementemic urticarial vasculitis. Arthritis Rheum 2013;65(8):2183–9. Cross Ref link Pubmed link
44 Berg RE, Kantor GR, Bergfeld WF. Urticarial vasculitis. Int J Dermatol 1988 Sep;27(7):468–72. Cross Ref link Pubmed link
45 Palazzo E, Bourgeois P, Meyer O, De Bandt M, Kazatchkine M, Kahn MF. Hypocomplementemic urticarial vasculitis syndrome, Jaccoud's syndrome, valvulopathy: a new syndromic combination. J Rheumatol 1993;20(7):1236–40. Pubmed link
46 Chen K‐R. Histopathology of Cutaneous Vasculitis, Advances in the Diagnosis and Treatment of Vasculitis. Dr Luis M. Amezcua‐Guerra, ed., InTech, 2011, http://www.intechopen.com/books/advances‐in‐the‐diagnosis‐and‐treatment‐of‐vasculitis/histopathology‐of cutaneous‐vasculitis (last checked by the author, April 2015).
47 Worm M, Sterry W, Kolde G. Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis. Br J Dermatol 2000;143(6):1324. Cross Ref link Pubmed link
48 Handfield‐Jones SE, Greaves MW. Urticarial vasculitis – response to gold therapy. J R Soc Med 1991;84(3):169. Pubmed link
49 Stack PS. Methotrexate for urticarial vasculitis. Ann Allergy 1994;72(1):36–8. Pubmed link
50 Staubach‐Renz P, von Stebut E, Bräuninger W, Maurer M, Steinbrink K. [Hypocomplementemic urticarial vasculitis syndrome. Successful therapy with intravenous immunoglobulins.] Hautarzt 2007;58(8):693–7. Cross Ref link Pubmed link
51 Alexander JL, Kalaaji AN, Shehan JM, Yokel BK, Pittelkow MR. Plasmapheresis for refractory urticarial vasculitis in a patient with B‐cell chronic lymphocytic leukemia. J Drug Dermatol 2006;5(6):534–7.
52 Botsios C, Sfriso P, Punzi L, Todesco S. Non‐complementaemic urticarial vasculitis: successful treatment with the IL‐1 receptor antagonist, anakinra. Scand J Rheumatol 2007;36(3):236–7. Cross Ref link Pubmed link
53 Makol A, Gibson LE, Michet CJ. Successful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis. J Clin Rheumatol 2012;18(2):92–5. Cross Ref link Pubmed link
54 Kai AC, Flohr C, Grattan CE. Improvement in quality of life impairment followed by relapse with 6‐monthly periodic administration of omalizumab for severe treatment‐refractory chronic urticaria and urticarial vasculitis. Clin Exp Dermatol 2014;39(5):651–2. Cross Ref link Pubmed link

Log in to Rooks online